Background : it has been suggested that vitamin C can modify the compo
sition of lipoproteins in healthy subjects. Objective : to determine t
he possible modification of lipid levels in the presence of vitamin C,
and the effect of various doses on lipid levels. Design : this is a s
equential open clinical trial, where the same individuals are used as
their own controls, and where the same observer at random administers
1 or 2 g of oral vitamin C during a month, followed by a further month
without treatment. Patients : 124 healthy volunteers of both sexes, b
etween 17 and 74 years of age, whose lifestyle was not modified during
the study. Measurement : at the beginning of the study a determinatio
n was made of lipid levels, risk factors such as age, physical activit
y, tobacco and alcohol use, weight and arterial pressure ; at the end
of the first month during vitamin C therapy, and again at the end of t
he second month without therapy, lipid levels were determined, namely,
TG, TC, HDL-C, HDL2-C, HDL3-C, LDL-C, ApoA1, ApoB and Lp(a). Results:
after one month of treatment with 2 grams of vitamin C, a significant
decrease of ApoB was observed, namely, 5.5 % in females and 8 % in ma
les (p = 0.019). Vitamin C treatment shows the following differential
data : a negative correlation of Lp(a) with HDL3-C, in both sexes ; in
males, the positive correlation of age with LDL-C and the negative co
rrelation of tobacco with HDL-C disappear, positive correlations appea
r between physical activity and HDL-C, between tobacco and LDL-C, betw
een weight and ApoB, between SBP and TG, and between DBP and ApoB ; in
females, the positive correlation between weight and TG, and the nega
tive correlation between weight and HDL-C both disappear, negative cor
relations appear between physical activity and both TC and ApoB, betwe
en weight and HDL3-C, a positive correlation appears between DBP and H
DL2-C. Compared to non-drinkers, in males who consume less than 50 gra
ms of alcohol daily, vitamin C produces a significant decrease in DHL3
-C, while the significant increase in Lp(a) disappears. Conclusions :
from the results in the follow-up of this group of healthy individuals
, it can be deduced that vitamin C produces a decrease in ApoB in both
sexes where 2 g are administered daily. When the risk factors are cor
related, the results vary substantially, particularly with reference t
o the sex of the individuals. Women benefit much more than men from vi
tamin C therapy, especially when physical activity, weight and diastol
ic blood pressure are considered. Compared to non-drinkers, male drink
ers demonstrate a decrease in HDL3-C, and the significant increase in
Lp(a) disappears.